v3.25.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Operating expenses:    
Research and development $ 13,012 $ 8,566
General and administrative 3,988 1,265
Total operating expenses 17,000 9,831
Loss from operations (17,000) (9,831)
Other income:    
Interest income 1,075 295
Net loss and comprehensive loss $ (15,925) $ (9,536)
Net loss per share attributable to common stockholders, basic $ (1.19) $ (30.37)
Net loss per share attributable to common stockholders, diluted $ (1.19) $ (30.37)
Weighted-average shares used in computing net loss per share, basic 13,424,335 314,016
Weighted-average shares used in computing net loss per share, diluted 13,424,335 314,016